12:00 AM
 | 
Apr 01, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Stribild elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate regulatory update

Japan Tobacco said the Japanese Ministry of Health, Labor and Welfare (MHLW) approved its NDA for Stribild to treat HIV-1 infection. Japan Tobacco's subsidiary Torii Pharmaceutical Co. Ltd. (Tokyo:2914; Osaka:2914, Tokyo, Japan) has exclusive commercialization rights to the product in Japan. Last August, FDA approved an application from Gilead for the...

Read the full 243 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >